Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · IEX Real-Time Price · USD
1.67
+0.03 (1.77%)
Feb 6, 2023, 2:46 PM EST - Market open
1.77%
Market Cap 5.16M
Revenue (ttm) 12.51M
Net Income (ttm) -5.79M
Shares Out 3.11M
EPS (ttm) -2.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 64,742
Open 1.61
Previous Close 1.64
Day's Range 1.60 - 1.67
52-Week Range 1.00 - 4.25
Beta 1.04
Analysts Buy
Price Target n/a
Earnings Date Feb 9, 2023

About SNOA

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing throug... [Read more]

Sector Healthcare
IPO Date Jan 25, 2007
Employees 12
Stock Exchange NASDAQ
Ticker Symbol SNOA
Full Company Profile

Financial Performance

In 2022, SNOA's revenue was $12.63 million, a decrease of -32.21% compared to the previous year's $18.63 million. Losses were -$5.09 million, 28.8% more than in 2021.

Financial Statements

News

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

BOULDER, CO / ACCESSWIRE / January 31, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorou...

6 days ago - Accesswire

Why Is Sonoma Pharmaceuticals (SNOA) Up 70% Today?

Sonoma Pharmaceuticals (NASDAQ: SNOA) stock is rocketing higher on Wednesday following positive news for its Microcyn Rx products. The big news here is Sonoma Pharmaceuticals getting a Distribution a...

1 week ago - InvestorPlace

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

BOULDER, CO / ACCESSWIRE / January 25, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorou...

1 week ago - Accesswire

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

BOULDER, CO / ACCESSWIRE / January 4, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...

1 month ago - Accesswire

Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results

International sales increased by 18% in the six months ended September 30, 2022 compared to the same period prior year Gross profit percentage continues to trend upwards with the quarter ended Septemb...

2 months ago - Accesswire

Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States

BOULDER, CO / ACCESSWIRE / October 27, 2022 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorou...

3 months ago - Accesswire

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany

BOULDER, CO / ACCESSWIRE / October 6, 2022 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide ran...

4 months ago - Accesswire

Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results

Revenue increase of 73% from Q4 22 and 8% from Q1 22 Reduction of net loss by $0.2 million or 19% versus Q1 22 Reduction of EBITDAS loss by $0.2 million or 23% versus Q1 22 Reduction in net loss per s...

6 months ago - Accesswire

Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply

WOODSTOCK, GA / ACCESSWIRE / August 2, 2022 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorou...

6 months ago - Accesswire

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results

Revenues increased 7% in Q4 2022 compared to Q4 2021 Net loss per share improved quarter over quarter and year over year Strong balance sheet with $7.4 million of cash WOODSTOCK, GA / ACCESSWIRE / Jul...

7 months ago - Accesswire

Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl...

8 months ago - Business Wire

Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?

Sonoma Pharmaceuticals (SNOA) stock is getting a boost on Tuesday after the company revealed positive disinfectant news from the EPA. The post Why Is Sonoma Pharmaceuticals (SNOA) Stock Up 30% Today?

9 months ago - InvestorPlace

Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S.

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl...

9 months ago - Business Wire

Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday and we know why! The post Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, G...

Other symbols: DRCTGERNNAOVVYNT
11 months ago - InvestorPlace

Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has launched Microdox, an urinary tract infection catheter and bladder rinse in New Zealand, Australia, and South Africa. Microdox is a super-oxidized solutio...

11 months ago - Benzinga

Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl...

11 months ago - Business Wire

Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of appli...

1 year ago - Business Wire

Sonoma Pharma Expands Its Partner Network For Oral, Dental Products In US & China

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) has added Salus Medical as an additional distribution partner in the U.S for dental care. The Company has also expanded its oral and dental care lines to Chin...

1 year ago - Benzinga

Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl...

1 year ago - Business Wire

Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of appli...

1 year ago - Business Wire

Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of appli...

1 year ago - Business Wire

Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of appli...

1 year ago - Business Wire

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of appli...

1 year ago - Business Wire

7 Popular Penny Stocks That You Shouldn't Touch With a 10-Foot Pole

Penny stocks can be risky investments. These seven popular penny stocks seem like particularly bad bets no matter how you look at it.

Other symbols: CEIFAMIHUSARWLKWTER
1 year ago - InvestorPlace

Why SNOA Stock Is Getting a Bezos-Sized Boost Today

Today, investors in Sonoma Pharmaceuticals and SNOA stock are seeing impressive gains as the company launches its products on Amazon. The post Why SNOA Stock Is Getting a Bezos-Sized Boost Today appea...

1 year ago - InvestorPlace